Cargando…
Aberrant expressions of miRNA-206 target, FN1, in multifactorial Hirschsprung disease
BACKGROUND: MicroRNAs (miRNAs) have been associated with the Hirschsprung disease (HSCR) pathogenesis, however, the findings are still inconclusive. We aimed to investigate the effect of miRNA-206 and its targets, fibronectin 1 (FN1), serum deprivation response (SDPR), and paired box 3 (PAX3) expres...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323865/ https://www.ncbi.nlm.nih.gov/pubmed/30616633 http://dx.doi.org/10.1186/s13023-018-0973-5 |
_version_ | 1783385857035599872 |
---|---|
author | Gunadi Budi, Nova Yuli Prasetyo Kalim, Alvin Santoso Santiko, Wiwid Musthofa, Fuad Dheni Iskandar, Kristy Makhmudi, Akhmad |
author_facet | Gunadi Budi, Nova Yuli Prasetyo Kalim, Alvin Santoso Santiko, Wiwid Musthofa, Fuad Dheni Iskandar, Kristy Makhmudi, Akhmad |
author_sort | Gunadi |
collection | PubMed |
description | BACKGROUND: MicroRNAs (miRNAs) have been associated with the Hirschsprung disease (HSCR) pathogenesis, however, the findings are still inconclusive. We aimed to investigate the effect of miRNA-206 and its targets, fibronectin 1 (FN1), serum deprivation response (SDPR), and paired box 3 (PAX3) expressions on multifactorial HSCR in Indonesia, a genetically distinct group within Asia. METHODS: We determined the miRNA-206, FN1, SDPR and PAX3 expressions in both the ganglionic and aganglionic colon of HSCR patients and control colon by quantitative real-time polymerase chain reaction (qRT-PCR). RESULTS: Twenty-one sporadic HSCR patients and thirteen controls were ascertained in this study. The miRNA-206 expression was up-regulated (2-fold) in the ganglionic colon and down-regulated (0.5-fold) in the aganglionic colon compared to the control group (ΔC(T) 12.4 ± 3.0 vs. 14.1 ± 3.9 vs. 13.1 ± 2.7), but these differences did not reach significant levels (p = 0.48 and p = 0.46, respectively). Interestingly, the FN1 expression was significantly increased in both the ganglionic (38-fold) and aganglionic colon (18-fold) groups compared to the control group ΔC(T) 5.7 ± 3.0 vs. 6.8 ± 2.3 vs. 11.0 ± 5.0; p = 0.001 and p = 0.038, respectively). Furthermore, the expressions of SDPR were similar in the ganglionic, aganglionic and control colon groups (ΔC(T) 2.4 ± 0.6 vs. 2.2 ± 0.4 vs. 2.1 ± 0.6; p = 0.16 and p = 0.39, respectively), while no change was observed in the PAX3 expression between the ganglionic, aganglionic, and control colon groups (ΔC(T) 3.8 ± 0.8 vs. 4.1 ± 0.8 vs. 3.7 ± 1.1; p = 0.83 and p = 0.44, respectively). CONCLUSION: Our study is the first report of aberrant FN1 expressions in the colon of patients with HSCR and supplies further insights into the contribution of aberrant FN1 expression in the HSCR pathogenesis. |
format | Online Article Text |
id | pubmed-6323865 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-63238652019-01-11 Aberrant expressions of miRNA-206 target, FN1, in multifactorial Hirschsprung disease Gunadi Budi, Nova Yuli Prasetyo Kalim, Alvin Santoso Santiko, Wiwid Musthofa, Fuad Dheni Iskandar, Kristy Makhmudi, Akhmad Orphanet J Rare Dis Research BACKGROUND: MicroRNAs (miRNAs) have been associated with the Hirschsprung disease (HSCR) pathogenesis, however, the findings are still inconclusive. We aimed to investigate the effect of miRNA-206 and its targets, fibronectin 1 (FN1), serum deprivation response (SDPR), and paired box 3 (PAX3) expressions on multifactorial HSCR in Indonesia, a genetically distinct group within Asia. METHODS: We determined the miRNA-206, FN1, SDPR and PAX3 expressions in both the ganglionic and aganglionic colon of HSCR patients and control colon by quantitative real-time polymerase chain reaction (qRT-PCR). RESULTS: Twenty-one sporadic HSCR patients and thirteen controls were ascertained in this study. The miRNA-206 expression was up-regulated (2-fold) in the ganglionic colon and down-regulated (0.5-fold) in the aganglionic colon compared to the control group (ΔC(T) 12.4 ± 3.0 vs. 14.1 ± 3.9 vs. 13.1 ± 2.7), but these differences did not reach significant levels (p = 0.48 and p = 0.46, respectively). Interestingly, the FN1 expression was significantly increased in both the ganglionic (38-fold) and aganglionic colon (18-fold) groups compared to the control group ΔC(T) 5.7 ± 3.0 vs. 6.8 ± 2.3 vs. 11.0 ± 5.0; p = 0.001 and p = 0.038, respectively). Furthermore, the expressions of SDPR were similar in the ganglionic, aganglionic and control colon groups (ΔC(T) 2.4 ± 0.6 vs. 2.2 ± 0.4 vs. 2.1 ± 0.6; p = 0.16 and p = 0.39, respectively), while no change was observed in the PAX3 expression between the ganglionic, aganglionic, and control colon groups (ΔC(T) 3.8 ± 0.8 vs. 4.1 ± 0.8 vs. 3.7 ± 1.1; p = 0.83 and p = 0.44, respectively). CONCLUSION: Our study is the first report of aberrant FN1 expressions in the colon of patients with HSCR and supplies further insights into the contribution of aberrant FN1 expression in the HSCR pathogenesis. BioMed Central 2019-01-07 /pmc/articles/PMC6323865/ /pubmed/30616633 http://dx.doi.org/10.1186/s13023-018-0973-5 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Gunadi Budi, Nova Yuli Prasetyo Kalim, Alvin Santoso Santiko, Wiwid Musthofa, Fuad Dheni Iskandar, Kristy Makhmudi, Akhmad Aberrant expressions of miRNA-206 target, FN1, in multifactorial Hirschsprung disease |
title | Aberrant expressions of miRNA-206 target, FN1, in multifactorial Hirschsprung disease |
title_full | Aberrant expressions of miRNA-206 target, FN1, in multifactorial Hirschsprung disease |
title_fullStr | Aberrant expressions of miRNA-206 target, FN1, in multifactorial Hirschsprung disease |
title_full_unstemmed | Aberrant expressions of miRNA-206 target, FN1, in multifactorial Hirschsprung disease |
title_short | Aberrant expressions of miRNA-206 target, FN1, in multifactorial Hirschsprung disease |
title_sort | aberrant expressions of mirna-206 target, fn1, in multifactorial hirschsprung disease |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323865/ https://www.ncbi.nlm.nih.gov/pubmed/30616633 http://dx.doi.org/10.1186/s13023-018-0973-5 |
work_keys_str_mv | AT gunadi aberrantexpressionsofmirna206targetfn1inmultifactorialhirschsprungdisease AT budinovayuliprasetyo aberrantexpressionsofmirna206targetfn1inmultifactorialhirschsprungdisease AT kalimalvinsantoso aberrantexpressionsofmirna206targetfn1inmultifactorialhirschsprungdisease AT santikowiwid aberrantexpressionsofmirna206targetfn1inmultifactorialhirschsprungdisease AT musthofafuaddheni aberrantexpressionsofmirna206targetfn1inmultifactorialhirschsprungdisease AT iskandarkristy aberrantexpressionsofmirna206targetfn1inmultifactorialhirschsprungdisease AT makhmudiakhmad aberrantexpressionsofmirna206targetfn1inmultifactorialhirschsprungdisease |